Atea Pharmaceuticals, Inc.
Clinical trials sponsored by Atea Pharmaceuticals, Inc., explained in plain language.
-
New pill combo shows promise against hepatitis c in Mid-Stage trial
Disease control CompletedThis study tested a combination of two oral drugs, bemnifosbuvir and ruzasvir, in 275 adults with chronic hepatitis C. The main goal was to see if the treatment could clear the virus from the blood 12 weeks after finishing therapy. The trial was open-label, meaning everyone knew …
Phase: PHASE2 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
Birth control pill interaction study for new hepatitis c drug
Knowledge-focused CompletedThis study looked at whether taking an experimental hepatitis C medication (bemnifosbuvir/ruzasvir) changes how a common birth control pill (ethinyl estradiol/levonorgestrel) works in the body. It involved 24 healthy women who were past menopause or surgically sterile. The goal w…
Phase: PHASE1 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 07:03 UTC